Item 7.01. | Regulation FD Disclosure. |
Premier, Inc. (the “Company”) is scheduled to present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Wednesday, January 9, 2019 at 1:30 p.m. Pacific Time. The presentation and subsequent breakout question and answer session will be audio webcast live through the investor relations page on the Company’s website atinvestors.premierinc.com, where presentation slides also will be made available. A webcast replay will be archived on the Company’s website for approximately 90 days.
Pursuant to Regulation FD, the Company hereby furnishes the presentation materials attached as Exhibit 99.1 to this Current Report on Form8-K, which information is incorporated into this Item 7.01 by this reference. A related press release announcing the Company’s participation in the conference is also attached as Exhibit 99.2 to this Current Report on Form8-K, which information is incorporated into this Item 7.01 by this reference.
The information in this Current Report on Form8-K under this Item 7.01, as well as Exhibit 99.1 and Exhibit 99.2, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing. The furnishing of this report is not intended to constitute a determination by the registrant that the information is material or that the dissemination of the information is required by Regulation FD.
The information included in this Current Report on Form8-K and any exhibits hereto will not be deemed an admission as to the materiality of any such information.
Use and Definition ofNon-GAAP Financial Measures
The financial data contained in the presentation materials attached hereto as Exhibit 99.1 includes financial measures that are not calculated in accordance with generally accepted accounting principles(“Non-GAAP”), including EBITDA, Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted Fully Distributed Net Income, Adjusted Fully Distributed Earnings per Share and Free Cash Flow, each as defined below.
The Company defines EBITDA as net income before interest and investment income, net, income tax expense, depreciation and amortization and amortization of purchased intangible assets. The Company defines Adjusted EBITDA as EBITDA before merger and acquisition related expenses andnon-recurring,non-cash ornon-operating items and including equity in net income of unconsolidated affiliates. For allNon-GAAP financial measures, the Company considersnon-recurring items to be income or expenses and other items that have not been earned or incurred within the prior two years and are not expected to recur within the next two years. Such items include certain strategic and financial restructuring expenses.Non-operating items include gains or losses on the disposal of assets and interest and investment income or expense.
The Company defines Segment Adjusted EBITDA as the segment’s net revenue less cost of revenue and operating expenses directly attributable to the segment, excluding depreciation and amortization, amortization of purchased intangible assets, merger and acquisition related expenses andnon-recurring ornon-cash items, and including equity in net income of unconsolidated affiliates. Operating expenses directly attributable to the segment include expenses associated with sales and marketing, general and administrative, and product development activities specific to the operation of each segment. General and administrative corporate expenses that are not specific to a particular segment are not included in the calculation of Segment Adjusted EBITDA.
The Company defines Adjusted Fully Distributed Net Income as net income attributable to the Company (i) excluding income tax expense, (ii) excluding the impact of adjustment of redeemable limited partners’ capital to redemption amount, (iii) excluding the effect ofnon-recurring andnon-cash items, (iv) assuming the exchange of all the Class B common units for shares of Class A common stock, which results in the elimination ofnon-controlling interest in Premier Healthcare Alliance, L.P., and (v) reflecting an adjustment for income tax expense onNon-GAAP fully distributed net income before income taxes at the Company’s estimated effective income tax rate. The Company defines Adjusted Fully Distributed Earnings per Share as Adjusted Fully Distributed Net Income divided by diluted weighted average shares.